Choose language
< Return to main menu
d2_ban.jpg weibiaoti-1-151.jpg

Drug Product

Services & Solutions

About Us

Services & Solutions

News

Resource

Contact

Career

Peptide CMC

Peptide Discovery

Peptide CMC

Peptide Conjugation

Amino Acid

Case Study

Drug Product

API

Drug Product

Analytical

CMC Filing

Our peptide drug product platform offers a comprehensive formulation service for oral solid and injectable dosage forms. The formulation team is supported by more than a thousand of scientists and state-of-the-art facilities at our integrated drug product R&D and manufacturing facilities in Wuxi city, Shanghai Waigaoqiao site in China.  Both two sites are within 2-hour drive to our peptide API site in Changzhou, providing an integrated peptide API and formulation development and manufacturing solution.

Oral Solid

Our oral solid platform provides a variety of dosage forms including tablets, capsules, powder, granules, liquid in bottle, liquid filled hard capsules and softgels with billions of doses annual capacity.  In 2021, the team evaluated 2500+ molecules in preformulation studies, delivered 1700+ clinical batches and worked on 20+ late phase and commercial projects

Sterile Injectable

Our injectable platform provide formulation development and manufacturing for solution, emulsion, lyophilized powder and liposome in vial, pre-filled syringe and cartridge. We currently have 1 injectable line (vials, pre-filled syringes and cartridges) in Shanghai Waigaoqiao and plan to add 2 more lines (vials, pre-filled syringes and cartridges) in Wuxi city by the end of 2022.